Clinical Trials in Pittsburgh

Showing 11061-11080 of 21,047 trials

Evaluation of Subchondroplasty™ for Defects Associated With Bone Marrow Lesions

NCT01621893

Studying long-term changes in a sub-set of patients who undergo the Subchondroplasty procedure including changes in pain, function, and overall health.

Bone Marrow Edema

Zimmer Biomet70 participantsStarted Mar 2012

Encinitas, California, United States • New Lenox, Illinois, United States • New York, New York, United States +3 more locations

TERMINATEDPhase 3< 1 mile

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

NCT02952586

This is a phase 3 randomized, placebo controlled study to evaluate the safety and anti-tumor activity of Avelumab in combination with standard of care chemoradiation (SoC CRT) versus SoC CRT alone in front-line treatment of patients with locally advanced head and neck cancer.

Squamous Cell Carcinoma of the Head and Neck

Pfizer697 participantsStarted Nov 2016

Fayetteville, Arkansas, United States • Rogers, Arkansas, United States • Springdale, Arkansas, United States +313 more locations

Evaluation of Subchondroplasty™ for Defects Associated With Bone Marrow Lesions

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

Find Trials by Condition in Pittsburgh

A Cohort Study of Operationally Tolerant Allograft Recipients

A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

A Pharmacokinetic Study of Sugammadex in Dialysis Patients

Onduo Virtual Diabetes Clinic Study

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Stress Management for Cancer Patients: How Well Does it Work? (C2H-D)

Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)

A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

Dose Range Study of CD5789 in Acne Vulgaris

OptiMesh® for Lumbar Interbody Fusion Trial (OLIF)

First in Human Study for Safety and Tolerability of AL003.

A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

Registry to Improve the Adoption of Consensus Treatment Guidelines (IMPROVE Brady)